Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maguire

Showing results (461-470 of 474) with videos related to

Pageof 48
Sort By:
BMC Public Health|March 30, 2023
A mixed methods study of Aboriginal health workers' and exercise physiologists' experiences of co-designing chronic lung disease 'yarning' education resourcesDavid P Meharg, Sarah M Dennis, Justin McNab, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Lung|November 7, 2019
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?Simone K Visser, Peter T P Bye, Greg J Fox, et al.
Respiratory Medicine|July 22, 2019
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis RegistrySimone K Visser, Peter T P Bye, Greg J Fox, et al.
Plos One|August 23, 2013
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trialAnna P Ralph, Govert Waramori, Gysje J Pontororing, et al.
Journal of Medicinal Chemistry|March 19, 2004
Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse modelTricia J Vos, Andrei Caracoti, Jennifer L Che, et al.
Epilepsia|March 30, 2019
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteersSjoerd J Finnema, Samantha Rossano, Mika Naganawa, et al.
The Medical Journal of Australia|February 20, 2013
Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) studyBrett G Toelle, Wei Xuan, Tessa E Bird, et al.
Nature Communications|October 30, 2024
Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumoniaNatasha Spottiswoode, Alexandra Tsitsiklis, Victoria T Chu, et al.
Nature Communications|November 28, 2013
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibitionQuentin M Anstee, Susanne Knapp, Edward P Maguire, et al.
Pageof 48

Showing results (461-470 of 474) with videos related to

Sort By:
Pageof 48
BMC Public Health|March 30, 2023
A mixed methods study of Aboriginal health workers' and exercise physiologists' experiences of co-designing chronic lung disease 'yarning' education resourcesDavid P Meharg, Sarah M Dennis, Justin McNab, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Lung|November 7, 2019
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?Simone K Visser, Peter T P Bye, Greg J Fox, et al.
Respiratory Medicine|July 22, 2019
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis RegistrySimone K Visser, Peter T P Bye, Greg J Fox, et al.
Plos One|August 23, 2013
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trialAnna P Ralph, Govert Waramori, Gysje J Pontororing, et al.
Journal of Medicinal Chemistry|March 19, 2004
Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse modelTricia J Vos, Andrei Caracoti, Jennifer L Che, et al.
Epilepsia|March 30, 2019
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteersSjoerd J Finnema, Samantha Rossano, Mika Naganawa, et al.
The Medical Journal of Australia|February 20, 2013
Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) studyBrett G Toelle, Wei Xuan, Tessa E Bird, et al.
Nature Communications|October 30, 2024
Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumoniaNatasha Spottiswoode, Alexandra Tsitsiklis, Victoria T Chu, et al.
Nature Communications|November 28, 2013
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibitionQuentin M Anstee, Susanne Knapp, Edward P Maguire, et al.
Pageof 48